In Which Tumor Burden Range Does Advanced Hepatocellular Carcinoma Patients Benefit More from Hepatic Arterial Infusion Chemotherapy Plus Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors Than Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors? a Multi-center, Retrospective, Propensity Score Matching Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06632106

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:26:08.850907+00:00

Published At

2024-10-08T00:00:00+00:00

Record Updated At

2024-10-08

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hepatic Arterial Infusion Chemotherapy", "Tyrosine Kinase Inhibitor", "Immune Checkpoint Inhibitors", "Hepatocellular Carcinoma (HCC)"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-10-08"

protocolSection.identificationModule.nctId

"NCT06632106"

protocolSection.identificationModule.officialTitle

"In Which Tumor Burden Range Does Advanced Hepatocellular Carcinoma Patients Benefit More from Hepatic Arterial Infusion Chemotherapy Plus Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors Than Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors? a Multi-center, Retrospective, Propensity Score Matching Study"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hepatic Arterial Infusion Chemotherapy (protocolSection.conditionsModule.conditions)
• Tyrosine Kinase Inhibitor (protocolSection.conditionsModule.conditions)
• Immune Checkpoint Inhibitors (protocolSection.conditionsModule.conditions)
• Hepatocellular Carcinoma (HCC) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.